Much ado about nothing

Methicillin-resistant Staphylococcus aureus

T. Shannon, P. Edgar, C. Villarreal, David Herndon, Linda Phillips, John P. Heggers

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

The pathogenic methicillin-resistant Staphylococcus aureus (MRSA) has received a voluminous amount of notoriety. The four major reasons are its morbidity, mortality rate, cost of treatment, and constant appearance in intensive care units. Both Staphylococcus aureus and S. epidermidis (MRSE) account for 82% of our gram-positive wound isolates, whereas the gram- negatives account for 34% of all isolates. Therefore we compared the morbidity, mortality rate, and cost factors related to MRSA-MRSE and gram- negative infections for a 4-year period, assessing more than 214 documented infections. Morbidity and mortality rates were minor for MRSA. Pseudomonas aeruginosa and Escherichia coli accounted for 57.5% of the total gram- negative isolates. Gram-negative antimicrobial therapy usually requires two therapeutic drugs, which increases morbidity and costs, whereas the staphylococci usually can be treated by one antimicrobial. During this period there were 47 gram-negative infectious requiring 10 to 15 additional days of hospital stay, with a daily antibiotic cost of $293.40. Costs for MRSA or MRSE are 28% less. Therefore our preoccupation with MRSA or MRSE infections is unwarranted and unsubstantiated.

Original languageEnglish (US)
Pages (from-to)326-331
Number of pages6
JournalJournal of Burn Care and Rehabilitation
Volume18
Issue number4
StatePublished - Jul 1997

Fingerprint

Methicillin-Resistant Staphylococcus aureus
Morbidity
Costs and Cost Analysis
Mortality
Infection
Staphylococcus
Health Care Costs
Pseudomonas aeruginosa
Intensive Care Units
Staphylococcus aureus
Length of Stay
Escherichia coli
Anti-Bacterial Agents
Wounds and Injuries
Therapeutics
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Rehabilitation
  • Surgery
  • Nursing(all)
  • Health Professions(all)
  • Emergency Medicine

Cite this

Shannon, T., Edgar, P., Villarreal, C., Herndon, D., Phillips, L., & Heggers, J. P. (1997). Much ado about nothing: Methicillin-resistant Staphylococcus aureus. Journal of Burn Care and Rehabilitation, 18(4), 326-331.

Much ado about nothing : Methicillin-resistant Staphylococcus aureus. / Shannon, T.; Edgar, P.; Villarreal, C.; Herndon, David; Phillips, Linda; Heggers, John P.

In: Journal of Burn Care and Rehabilitation, Vol. 18, No. 4, 07.1997, p. 326-331.

Research output: Contribution to journalArticle

Shannon, T, Edgar, P, Villarreal, C, Herndon, D, Phillips, L & Heggers, JP 1997, 'Much ado about nothing: Methicillin-resistant Staphylococcus aureus', Journal of Burn Care and Rehabilitation, vol. 18, no. 4, pp. 326-331.
Shannon T, Edgar P, Villarreal C, Herndon D, Phillips L, Heggers JP. Much ado about nothing: Methicillin-resistant Staphylococcus aureus. Journal of Burn Care and Rehabilitation. 1997 Jul;18(4):326-331.
Shannon, T. ; Edgar, P. ; Villarreal, C. ; Herndon, David ; Phillips, Linda ; Heggers, John P. / Much ado about nothing : Methicillin-resistant Staphylococcus aureus. In: Journal of Burn Care and Rehabilitation. 1997 ; Vol. 18, No. 4. pp. 326-331.
@article{11d9cb198eac4625b6cc16ccbfe2f9d2,
title = "Much ado about nothing: Methicillin-resistant Staphylococcus aureus",
abstract = "The pathogenic methicillin-resistant Staphylococcus aureus (MRSA) has received a voluminous amount of notoriety. The four major reasons are its morbidity, mortality rate, cost of treatment, and constant appearance in intensive care units. Both Staphylococcus aureus and S. epidermidis (MRSE) account for 82{\%} of our gram-positive wound isolates, whereas the gram- negatives account for 34{\%} of all isolates. Therefore we compared the morbidity, mortality rate, and cost factors related to MRSA-MRSE and gram- negative infections for a 4-year period, assessing more than 214 documented infections. Morbidity and mortality rates were minor for MRSA. Pseudomonas aeruginosa and Escherichia coli accounted for 57.5{\%} of the total gram- negative isolates. Gram-negative antimicrobial therapy usually requires two therapeutic drugs, which increases morbidity and costs, whereas the staphylococci usually can be treated by one antimicrobial. During this period there were 47 gram-negative infectious requiring 10 to 15 additional days of hospital stay, with a daily antibiotic cost of $293.40. Costs for MRSA or MRSE are 28{\%} less. Therefore our preoccupation with MRSA or MRSE infections is unwarranted and unsubstantiated.",
author = "T. Shannon and P. Edgar and C. Villarreal and David Herndon and Linda Phillips and Heggers, {John P.}",
year = "1997",
month = "7",
language = "English (US)",
volume = "18",
pages = "326--331",
journal = "Journal of Burn Care and Research",
issn = "1559-047X",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - Much ado about nothing

T2 - Methicillin-resistant Staphylococcus aureus

AU - Shannon, T.

AU - Edgar, P.

AU - Villarreal, C.

AU - Herndon, David

AU - Phillips, Linda

AU - Heggers, John P.

PY - 1997/7

Y1 - 1997/7

N2 - The pathogenic methicillin-resistant Staphylococcus aureus (MRSA) has received a voluminous amount of notoriety. The four major reasons are its morbidity, mortality rate, cost of treatment, and constant appearance in intensive care units. Both Staphylococcus aureus and S. epidermidis (MRSE) account for 82% of our gram-positive wound isolates, whereas the gram- negatives account for 34% of all isolates. Therefore we compared the morbidity, mortality rate, and cost factors related to MRSA-MRSE and gram- negative infections for a 4-year period, assessing more than 214 documented infections. Morbidity and mortality rates were minor for MRSA. Pseudomonas aeruginosa and Escherichia coli accounted for 57.5% of the total gram- negative isolates. Gram-negative antimicrobial therapy usually requires two therapeutic drugs, which increases morbidity and costs, whereas the staphylococci usually can be treated by one antimicrobial. During this period there were 47 gram-negative infectious requiring 10 to 15 additional days of hospital stay, with a daily antibiotic cost of $293.40. Costs for MRSA or MRSE are 28% less. Therefore our preoccupation with MRSA or MRSE infections is unwarranted and unsubstantiated.

AB - The pathogenic methicillin-resistant Staphylococcus aureus (MRSA) has received a voluminous amount of notoriety. The four major reasons are its morbidity, mortality rate, cost of treatment, and constant appearance in intensive care units. Both Staphylococcus aureus and S. epidermidis (MRSE) account for 82% of our gram-positive wound isolates, whereas the gram- negatives account for 34% of all isolates. Therefore we compared the morbidity, mortality rate, and cost factors related to MRSA-MRSE and gram- negative infections for a 4-year period, assessing more than 214 documented infections. Morbidity and mortality rates were minor for MRSA. Pseudomonas aeruginosa and Escherichia coli accounted for 57.5% of the total gram- negative isolates. Gram-negative antimicrobial therapy usually requires two therapeutic drugs, which increases morbidity and costs, whereas the staphylococci usually can be treated by one antimicrobial. During this period there were 47 gram-negative infectious requiring 10 to 15 additional days of hospital stay, with a daily antibiotic cost of $293.40. Costs for MRSA or MRSE are 28% less. Therefore our preoccupation with MRSA or MRSE infections is unwarranted and unsubstantiated.

UR - http://www.scopus.com/inward/record.url?scp=0030856482&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030856482&partnerID=8YFLogxK

M3 - Article

VL - 18

SP - 326

EP - 331

JO - Journal of Burn Care and Research

JF - Journal of Burn Care and Research

SN - 1559-047X

IS - 4

ER -